This virtual event welcomes clinicians, pathologists, and lab directors interested in investigating the many benefits of Comprehensive Genomic Profiling (CGP) Testing! Tissue stewardship, testing consolidation, and ability to assess current and emerging biomarkers, are one of many advantages of CGP testing implementation. One biopsy, one test, one report can lead to improved patient outcomes.
This 4-hr event, occurring on Tuesday, June 18th, features presentations from leading pathologists and genomic specialists. Presentations will highlight a broad range of topics empowering broader access to precision oncology, including the driving advances of CGP throughout institutions in addition to real-world evidence that demonstrates the clinical utility in both academic and community oncology practices.
Attend this event and you will have the opportunity to:
Learn how clinicians at the forefront of their field are leveraging existing technologies and developing new methods to identify the most appropriate therapy decisions to improve patient outcomes
Network with likeminded individuals and potential collaborators
Understand the benefits of Illumina technology throughout the cancer patient journey
Explore a virtual exhibit where you will find a broad range of education content, Illumina application information, and peer-reviewed publications highlighting evidence on the utility of genomics in oncology testing
Sr. Medical Director,
Clinical Genomics
Illumina
Director of Molecular Pathology and Pathology Informatics
Providence St. Joseph Health
Chief Scientific Officer and Director Genomics Technologies
OmniSeq Inc., Roswell Park Comprehensive Cancer Center
Associate Member at Earle A. Chiles Research Institute
Technical Director Clinical Genomics at Providence St. Joseph Health
Associate Director Medical Affairs, Illumina
Associate Professor & Director Molecular Pathology
University of Vermont
Larner College of Medicine
Pathologist
Intermountain Health